Table 3.
Additional pullulan-based hydrogels wound dressings.
| Application | System Used | Drug/Growth Enhancing Factor(s) | Cell Types Treated | Reference |
|---|---|---|---|---|
| Wound healing | Pullulan film | - | Rat skin cells | [88] |
| Wound dressing | Keratin/pullulan/PVA hydrogel membrane | Cefotaxime | Incision on male SD rat skin cells | [89] |
| Wound dressing and antibacterial effect | Carboxymethyl pullulan hydrogels | Gentamicin | In vitro drug release studies in phosphate buffer saline solution | [90] |
| Wound healing | Hyaluronic/pullulan/ grafted-Pluronic F127 hydrogel |
Curcumin | Female rat skin cells | [91] |
| High oxidative stress wound dressing | Pullulan hydrogels | Mesenchymal stromal cell | Anterior and posterior full thickness transverse incisions on skin cells | [92] |
| Wound dressing | Pullulan/dopamine hydrogel | - | In vitro studies of sheep blood | [93] |
| Wound healing | Pullulan/chitosan composite nanofibers | Tannic acid | NIH 3T3 mouse embryonic fibroblast cells | [94] |
| Wound dressing and antioxidant effect | Pullulan/bacterial cellulose hydrogel | Vitamin C and E | In vitro studies in phosphate saline buffer | [95] |
| Early cutaneous wound healing | Pullulan/collagen composite hydrogels | - | Full thickness skin cells incisions | [96] |
| Wound dressing | Collagen/pullulan hydrogel | Polydatin | Wistar rat skin cells | [97] |
| Wound healing | Cholesterol bearing pullulan nanogels | Prostaglandin E1 | Full thickness defect on rat dermal cells | [98] |
| Wound dressing and drug delivery system | Pu-g-p(AA-co-IA) hydrogel film | Ampicillin | In vitro drug release study in phosphate buffer saline solution | [99] |
Pu-g-p(AA-co-IA) = Pullulan grafted poly(acrylic acid-co-itaconic acid); PVA = Polyvinyl alcohol.